In vitro vasoactivity of zerumbone from Zingiber zerumbet

Planta Medica

Volumn 81, Issue 4, 2015, Pages 298-304

  Fusi, Fabio ^a   Durante, Miriam ^a   Sgaragli, Giampietro ^a   Khanh, Pham Ngoc ^b   Son, Ninh The ^b   Huong, Tran Thu ^b   Huong, Van Ngoc ^c   Cuong, Nguyen Manh ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b GRADUATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Viet Nam)

^c VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

Author keywords

L type Ca2+ channel; vascular smooth muscle; whole cell patch clamp; zerumbone; Zingiber zerumbet; Zingiberaceae

Indexed keywords

BARIUM ION; CALCIUM; CALCIUM CHANNEL L TYPE; NIFEDIPINE; POTASSIUM; VERAPAMIL; ZERUMBONE; CALCIUM CHANNEL; CHOLINERGIC RECEPTOR BLOCKING AGENT; PHENYLEPHRINE; PLANT EXTRACT; SESQUITERPENE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG ISOLATION; DRUG POTENCY; DRUG PURIFICATION; DRUG SAFETY; ENDOTHELIUM; IC50; IN VITRO STUDY; MALE; MUSCLE RELAXATION; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; SPASMOLYSIS; SPASMOLYTIC ACTIVITY; VASCULAR RING; VASODILATATION; ZINGIBER ZERUMBET; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; RHIZOME; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WISTAR RAT; ZINGIBERACEAE;

ANIMALS; CALCIUM; CALCIUM CHANNELS; IN VITRO TECHNIQUES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PARASYMPATHOLYTICS; PHENYLEPHRINE; PLANT EXTRACTS; RATS, WISTAR; RHIZOME; SESQUITERPENES; VASOCONSTRICTION; VASODILATION; ZINGIBERACEAE;

EID: 84925497919     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1396307     Document Type: Article

References (31)

1. Newman D. J., Cragg G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod: 2012; 75 311 335
2. Yob N. J., Jofrry S. M., Affandi M. M., The L. K., Salleh M. Z., Zakaria Z. A. Zingiber zerumbet (L.) Smith: a review of its ethnomedicinal, chemical, and pharmacological uses. Evid Based Complement Alternat Med: 2011; 2011 543216
3. Huong V. N., Thu N. TM, Huong N. T., Nguyet L. TM, Cuong N. M., Binh N. Q. Determination of essential oil and zerumbone content of Zingiber zerumbet Sm. rhizome in some provinces of North Vietnam. J Chem Appl: 2011; 3 23 25 32
4. Terry R., Posadzki P., Watson L. K., Ernst E. The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain Med: 2011; 12 1808 1818
5. Batubara I., Suparto I. H., Sadiah S., Matsuoka R., Mitsunaga T. Effect of Zingiber zerumbet essential oils and zerumbone inhalation on body weight of Sprague Dawley rat. Pak J Biol Sci: 2013; 16 1028 1033
6. Prasannan R., Kalesh K. A., Shanmugam M. K., Nachiyappan A., Ramachandran L., Nguyen A. H., Kumar A. P., Lakshmanan M., Ahn K. S., Sethi G. Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. Biochem Pharmacol: 2012; 84 1268 1276
7. Li F., Sethi G. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta: 2010; 1805 167 180
8. Murakami A., Matsumoto K., Koshimizu K., Ohigashi H. Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IkB degradation in RAW264.7 macrophages. Cancer Lett: 2003; 195 17 25
9. Chien T. Y., Chen L. G., Lee C. J., Lee F. Y., Wang C. C. Anti-inflammatory constituents of Zingiber zerumbet. Food Chem: 2008; 110 584 589
10. Saidu Y., Bilbis L. S., Lawal M., Isezuo S. A., Hassan S. W., Abbas A. Y. Acute and sub-chronic toxicity studies of crude aqueous extract of Albizzia chevalieri Harms (Leguminosae). Asian J Biochem: 2007; 2 224 236
11. Pugsley M. K., Authier S., Curtis M. J. Principles of safety pharmacology. Br J Pharmacol: 2008; 154 1382 1399
12. Kitayama T., Yokoi T., Kawai Y., Hill R. K., Morita M., Okamoto T., Yamamoto Y., Fokin V. V., Sharpless K. B., Sewada S. The chemistry of zerumbone. Part 5: Structural transformation of the dimethylamine derivatives. Tetrahedron: 2003; 59 4857 4866
13. 2+ channels in rat aorta smooth muscle cells in primary culture. Circul Res: 1990; 67 469 480
14. Karaki H. Use of tension measurements to delineate the mode of action of vasodilators. J Pharmacol Methods: 1987; 18 1 21
15. Bean B. P. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci U S A: 1984; 81 6388 6392
16. Kuriyama H., Kitamura K., Nabata H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol Rev: 1995; 47 387 573
17. McDonald T. F., Pelzer S., Trautwein W., Pelzer D. J. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev: 1994; 74 365 507
18. Su C. M., Swamy V. C., Triggle D. J. Calcium channel activation in vascular smooth muscle by BAY K 8644. Can J Physiol Pharmacol: 1984; 62 1401 1410
19. Nelson M. T., Quayle J. M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol: 1995; 268 C799 C822
20. Norman N. R., Toombs C. F., Khan S. A., Buchanan L. V., Cimini M. G., Gibson J. K., Meisheri K. D., Shebuski R. J. Comparative effects of the potassium channel openers cromakalin and pinacidil and the cromakalin analog U-89232 on isolated vascular and cardiac tissue. Pharmacology: 1994; 49 86 95
21. Saponara S., Kawase M., Shah A., Motohashi N., Molnar J., Ugocsai K., Sgaragli G., Fusi F. 3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility. Br J Pharmacol: 2004; 141 415 422
22. Timin E. N., Berjukow S., Hering S. Concepts of state-dependent pharmacology of calcium channels. In: McDonough S. I. editor Calcium channel pharmacology. New York Kluwer Academic/Plenum Publishers: 2004; 1 19
23. 2+ channel blocking activity of sulphur-containing indole alkaloids from Glycosmis petelotii. J Nat Prod: 2014; 77 1586 1593
24. Rahman H. S., Rasedee A., Yeap S. K., Othman H. H., Chartrand M. S., Namvar F., Abdul A. B., How C. W. Biomedical properties of a natural dietary plant metabolite, zerumbone, in cancer therapy and chemoprevention trials. Biomed Res Int: 2014; 2014 920742
25. Fusi F., Durante M., Sgaragli G., Cuong N. M., Dung P. TP, Nam N. H. 2-Aryl- and 2-amido-benzothiazoles as multifunctional vasodilators on rat artery preparations. Eur J Pharmacol: 2013; 714 178 187
26. B receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension. Braz J Med Biol Res: 2002; 35 1061 1068
27. 2+ channel via superoxide anion generation. Br J Pharmacol: 2001; 133 988 996
28. 2+ channel current characteristics are preserved in rat tail artery myocytes after one-day storage. Acta Physiol: 2014; 211 334 345
29. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch: 1981; 391 85 100
30. v 1.2 current. Eur J Pharmacol: 2012; 680 22 27
31. Stansfeld C., Mathie A. Recording membrane currents of peripheral neurones in short-term culture. In: Wallis D. I. editor Electrophysiology. A practical approach. Oxford IRL Press: 1993; 3 28